Abdalla R. Mohamed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Abdalla R. Mohamed has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
Hanan H. Georgey
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, Cairo, 11562, Egypt; Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Drug Technology, Egyptian Chinese University, 11786, Cairo, Egypt
5 shared publicationsNagwa M. Abdel Gawad
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, Cairo, 11562, Egypt
4 shared publicationsAhmed M. El Kerdawy
School of Health and Care Sciences, College of Health and Science, University of Lincoln, Joseph Banks Laboratories, Green Lane, Lincoln, United Kingdom; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, Cairo, 11562, Egypt
3 shared publications- Riham F. George
Pharmaceutical Chemistry Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt
3 shared publications Abdullah Y.A. Alzahrani
Department of Chemistry, Faculty of Science, King Khalid University, Abha, 61413, Saudi Arabia
2 shared publications- Claudiu Trandafir Supuran
Department of NEUROFARBA, Section of Pharmaceutical and Nutraceutical Sciences, University of Florence, Polo Scientifico, Via U. Schiff 6, Sesto Fiorentino, Firenze, 50019, Italy
2 shared publications
Latest Publications
- 10 June 2025
- Published by Wiley in Drug Development Research
- Vol. 86 (4) , e70116
Oxindole–Coumarin Hybrids With Broad‐Spectrum Anticancer Activity: Apoptosis Induction and Selective CA IX/XII Targeting
A scaffold hybridization approach was utilized to enhance the antitumor and carbonic anhydrase inhibitory activity of our oxindole and coumarin lead compounds (V and X). Two oxindole‐coumarin hybrids 6c and 6e showed broad spectrum of anticancer activity with NCI full panel MG‐MIDs of 5.01 and 6.31 µM, respectively. They revealed GI50 of a single digit micromolar concentration against 46 and 39 cell lines, respectively. An apoptosis dependent mechanism is suggested for the potent anticancer activity of compounds 6c and 6e via the increase in the BAX/BCL‐2 ratio and enhancement of the expression levels of caspase‐9 and the tumor suppressor p53. While this structure hybridization resulted in enhanced antitumor activity, it resulted in moderate CA IX and XII inhibitory activity. The potent anticancer compound 6e was among the most active inhibitors of the tumor associated CA IX and CA XII in this study (KI = 1.8 and 2.1 μM, respectively). As a result, even compound 6e's moderate CA IX/XII inhibitory activity may have synergistic effects contributing to its increased tumor growth suppression and proapoptotic activity. Moreover, compound 6e revealed a nonsignificant cytotoxicity toward the normal kidney epithelial Vero cell line and was totally inactive against the cytosolic isoforms CA I and CA II (KI = > 100 μM) which mitigate its side effect as chemotherapeutic agent and enforce its safety profile.
- 10 June 2025
- Published by Wiley in Drug Development Research
- Vol. 86 (4) , e70116
Oxindole–Coumarin Hybrids With Broad‐Spectrum Anticancer Activity: Apoptosis Induction and Selective CA IX/XII Targeting
A scaffold hybridization approach was utilized to enhance the antitumor and carbonic anhydrase inhibitory activity of our oxindole and coumarin lead compounds (V and X). Two oxindole‐coumarin hybrids 6c and 6e showed broad spectrum of anticancer activity with NCI full panel MG‐MIDs of 5.01 and 6.31 µM, respectively. They revealed GI50 of a single digit micromolar concentration against 46 and 39 cell lines, respectively. An apoptosis dependent mechanism is suggested for the potent anticancer activity of compounds 6c and 6e via the increase in the BAX/BCL‐2 ratio and enhancement of the expression levels of caspase‐9 and the tumor suppressor p53. While this structure hybridization resulted in enhanced antitumor activity, it resulted in moderate CA IX and XII inhibitory activity. The potent anticancer compound 6e was among the most active inhibitors of the tumor associated CA IX and CA XII in this study (KI = 1.8 and 2.1 μM, respectively). As a result, even compound 6e's moderate CA IX/XII inhibitory activity may have synergistic effects contributing to its increased tumor growth suppression and proapoptotic activity. Moreover, compound 6e revealed a nonsignificant cytotoxicity toward the normal kidney epithelial Vero cell line and was totally inactive against the cytosolic isoforms CA I and CA II (KI = > 100 μM) which mitigate its side effect as chemotherapeutic agent and enforce its safety profile.
- 26 August 2024
- Published by Elsevier in Bioorganic Chemistry
- Vol. 152, 107759
Mitigating the resistance of MCF-7 cancer cells to Doxorubicin under hypoxic conditions with novel coumarin based carbonic anhydrase IX and XII inhibitors
- 26 August 2024
- Published by Elsevier in Bioorganic Chemistry
- Vol. 152, 107759
Mitigating the resistance of MCF-7 cancer cells to Doxorubicin under hypoxic conditions with novel coumarin based carbonic anhydrase IX and XII inhibitors
- Open Access
- 25 January 2024
- Published by Egyptian Knowledge Bank in ERU Research Journal
- Vol. 3 (1) , 849-870
Digging into biochemical and signal transduction of old drugs: xanthines and their association to cancer
The arena of anticancer drug research has identified xanthine derivatives as intriguing molecules with diverse antimutagenic capabilities against a variety of cancer disorders. Xanthines are purine bases, which are known to act as non-selective and multitargeting agents of several cellular proteins. Natural xanthine analogues were reported to inhibit adenosine and phosphodiesterase subfamilies. Additionally, the effect toward several biochemical and signal transduction changes were studied to observe the efficiency of xanthine derivatives as anticancer agents and/or adjuvants. Several xanthine-based compounds were synthesized and introduced to obtain more selective and potent agents, which are demonstrated as research tools and possible therapeutic agents. The present minireview article illustrates the potential searching for efficacious rule of xanthine derivatives regarding several malignancies covering leukemia, melanoma, colon, CNS, ovarian, renal, prostate, non-small cell lung carcinoma and breast cancers. Further, an attempt to explain the biochemical effect of xanthines toward the complex signaling network of tumor cells was highlighted
- 25 January 2024
- Published by Egyptian Knowledge Bank in ERU Research Journal
- Vol. 3 (1) , 849-870
Open AccessDigging into biochemical and signal transduction of old drugs: xanthines and their association to cancer
The arena of anticancer drug research has identified xanthine derivatives as intriguing molecules with diverse antimutagenic capabilities against a variety of cancer disorders. Xanthines are purine bases, which are known to act as non-selective and multitargeting agents of several cellular proteins. Natural xanthine analogues were reported to inhibit adenosine and phosphodiesterase subfamilies. Additionally, the effect toward several biochemical and signal transduction changes were studied to observe the efficiency of xanthine derivatives as anticancer agents and/or adjuvants. Several xanthine-based compounds were synthesized and introduced to obtain more selective and potent agents, which are demonstrated as research tools and possible therapeutic agents. The present minireview article illustrates the potential searching for efficacious rule of xanthine derivatives regarding several malignancies covering leukemia, melanoma, colon, CNS, ovarian, renal, prostate, non-small cell lung carcinoma and breast cancers. Further, an attempt to explain the biochemical effect of xanthines toward the complex signaling network of tumor cells was highlighted
- 21 March 2023
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 14 (5) , 899-920
Insights into targeting SARS-CoV-2: design, synthesis,in silicostudies and antiviral evaluation of new dimethylxanthine derivatives
The expanded structure- and ligand-based drug design strategy was utilized to obtain a multitargeting SARS-CoV-2 inhibitor, compound 9a, with an IC50value of 8.86 μM.
- 21 March 2023
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 14 (5) , 899-920
Insights into targeting SARS-CoV-2: design, synthesis,in silicostudies and antiviral evaluation of new dimethylxanthine derivatives
The expanded structure- and ligand-based drug design strategy was utilized to obtain a multitargeting SARS-CoV-2 inhibitor, compound 9a, with an IC50value of 8.86 μM.
- 17 October 2022
- Published by Wiley in Chemistry & Biodiversity
- Vol. 19 (10) , e202200328
A Perspective Study on the RTK, PI3K, B‐Raf, CDK and the Multi‐Protein Targeting in Medicinal Chemistry
The cellular signaling pathway components that control the different stages of cell maturation such as RTK, PI3K, B‐Raf, and CDK represent crucial antitumor drug targets. The isoform diversity of these components revealed multi‐divergent vents for cancer cells to develop several resistance mechanisms against these new selective drug targets. This review article illustrates the complex nature of cancer, moreover, molecular tracing of tumor resistance towards certain signaling pathways was presented. Several crucial interventions in this regard for antitumor agents’ development were pointed out. The antitumor activities of several cancer chemotherapies targeting kinases were also discussed with a special focus on the structural bases for the design of protein kinase inhibitors. Additionally, a focused literature survey about the various targeted multi‐kinase inhibition approaches as a mean to overcome cancer resistance was also included.
- 17 October 2022
- Published by Wiley in Chemistry & Biodiversity
- Vol. 19 (10) , e202200328
A Perspective Study on the RTK, PI3K, B‐Raf, CDK and the Multi‐Protein Targeting in Medicinal Chemistry
The cellular signaling pathway components that control the different stages of cell maturation such as RTK, PI3K, B‐Raf, and CDK represent crucial antitumor drug targets. The isoform diversity of these components revealed multi‐divergent vents for cancer cells to develop several resistance mechanisms against these new selective drug targets. This review article illustrates the complex nature of cancer, moreover, molecular tracing of tumor resistance towards certain signaling pathways was presented. Several crucial interventions in this regard for antitumor agents’ development were pointed out. The antitumor activities of several cancer chemotherapies targeting kinases were also discussed with a special focus on the structural bases for the design of protein kinase inhibitors. Additionally, a focused literature survey about the various targeted multi‐kinase inhibition approaches as a mean to overcome cancer resistance was also included.
- 14 April 2022
- Published by Elsevier in Bioorganic Chemistry
- Vol. 124, 105807
Design, synthesis and anti-Mycobacterium tuberculosis evaluation of new thiazolidin-4-one and thiazolo[3,2-a][1,3,5]triazine derivatives
- 14 April 2022
- Published by Elsevier in Bioorganic Chemistry
- Vol. 124, 105807
Design, synthesis and anti-Mycobacterium tuberculosis evaluation of new thiazolidin-4-one and thiazolo[3,2-a][1,3,5]triazine derivatives
- Open Access
- 1 April 2022
- Published by Pleiades Publishing Ltd in Russian Journal of Bioorganic Chemistry
- Vol. 48 (2) , 438-456
Identification of Some Promising Heterocycles Useful in Treatment of Allergic Rhinitis: Virtual Screening, Pharmacophore Mapping, Molecular Docking, and Molecular Dynamics
Rhinitis is an allergic disease that causes troubles and restlessness for patients. In this research work we will focus on finding promising organic molecules with potential ability to target histamine receptor with no sedative side effect. Phalazines and their isosteres, pyrimidines and pyridines have been reported to target H1 receptors, for this reason we have searched for library of these basic scaffolds, this library which has 184 organic molecules will be subjected for further explorations through computer aided drug design techniques. Swiss ADMET will be used to gather these compounds in clusters. Cluster with low potential to penetrate BBB is selected for virtual screening through pharmacophore model. Then molecular docking that revealed the stability of the complex formed between the investigated molecules and H1 receptor. ADMET profile showed three compounds (XVIII), (XX), and (XXI) with no toxicity on liver and no effect on CYP2D6, these three compounds were subjected to molecular dynamic simulations and compound (XVIII) showed the most stable complex with the target protein (H1). Finally, we can say this work helped us to find new compounds with promising potential to target H1 without ability to penetrate BBB, so they can be used as useful candidates in treatment of rhinitis and deserve to be subjected for preclinical and clinical investigations.
- 1 April 2022
- Published by Pleiades Publishing Ltd in Russian Journal of Bioorganic Chemistry
- Vol. 48 (2) , 438-456
Open AccessIdentification of Some Promising Heterocycles Useful in Treatment of Allergic Rhinitis: Virtual Screening, Pharmacophore Mapping, Molecular Docking, and Molecular Dynamics
Rhinitis is an allergic disease that causes troubles and restlessness for patients. In this research work we will focus on finding promising organic molecules with potential ability to target histamine receptor with no sedative side effect. Phalazines and their isosteres, pyrimidines and pyridines have been reported to target H1 receptors, for this reason we have searched for library of these basic scaffolds, this library which has 184 organic molecules will be subjected for further explorations through computer aided drug design techniques. Swiss ADMET will be used to gather these compounds in clusters. Cluster with low potential to penetrate BBB is selected for virtual screening through pharmacophore model. Then molecular docking that revealed the stability of the complex formed between the investigated molecules and H1 receptor. ADMET profile showed three compounds (XVIII), (XX), and (XXI) with no toxicity on liver and no effect on CYP2D6, these three compounds were subjected to molecular dynamic simulations and compound (XVIII) showed the most stable complex with the target protein (H1). Finally, we can say this work helped us to find new compounds with promising potential to target H1 without ability to penetrate BBB, so they can be used as useful candidates in treatment of rhinitis and deserve to be subjected for preclinical and clinical investigations.